Christopher Gaffney

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy”.

The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy

Cancer(2023)10.1002/cncr.34981

N/A

0.442DataRank · unranked

18 citations

Amy L. Tin, Jonathan Fainberg, Samson W. Fine, Ghalib Jibara, Karim Touijer +6 more

Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.07.007

N/A

0.330DataRank · unranked

8 citations

Christopher Gaffney, Sanaz Firouzi, Wesley Yip, Andreas Aulitzky, Eugene J. Pietzak +11 more

Randomized Trial of Transverse vs Vertical Extraction Site Incision After Robotic Radical Prostatectomy

The Journal of Urology(2024)10.1097/ju.0000000000004066

N/A

0.292DataRank · unranked

6 citations

Emily Vertosick, Vincent P. Laudone, Alvin C. Goh, Sigrid Carlsson, Eugene J. Pietzak +6 more

A randomized comparison of two-stage versus traditional one-stage consent for a low-stakes randomized trial

Clinical Trials(2023)10.1177/17407745231185058

N/A

0.196DataRank · unranked

2 citations

Emily Vertosick, Mia Austria, Christopher Gaffney, Sigrid Carlsson, Scott Y. H. Kim +2 more

An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4614

N/A

0DataRank · unranked

0 citations

Christopher Gaffney, Christian Hernández, Patricia Morán, Kara Worth, Melissa McCarter +9 more

MP51-03 PROSTATE TUMOR SIZE IS INDEPENDENTLY ASSOCIATED WITH GENOMIC RISK

The Journal of Urology(2020)10.1097/ju.0000000000000913.03

N/A

0DataRank · unranked

0 citations

Deli Liu, Cynthia Angulo, Peter Y. Cai, Simpa S. Salami, Srinivas Nallandhighal +3 more

Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging–targeted prostate biopsy grade groups are discordant

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf275

N/A

0DataRank · unranked

1 citations

Targeted Biopsies Prostate Cancer Collaborative Group, Francesco Montorsi, Alberto Briganti, Armando Stabile, Amy L. Tin +57 more

Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity

Cell Reports(2021)10.1016/j.celrep.2021.109625

N/A

0DataRank · unranked

49 citations

Michael A. Augello, Deli Liu, Dylan McNally, Christopher Gaffney, Dennis Huang +12 more

A multidisciplinary approach to optimize primary prostate cancer biobanking

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.03.015

N/A

0DataRank · unranked

5 citations

Muhammad Asad, Michael A. Augello, Laura Martin, Christopher Louie, Spyridon P. Basourakos +10 more

A brief mind-body intervention to reduce pain and anxiety during prostate needle biopsy: a clinically integrated randomized controlled trial with 2-staged consent

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.09.016

N/A

0DataRank · unranked

7 citations

Emily Vertosick, Sigrid Carlsson, Xin Lin, Natalie C. Wolchasty, Robin Hardbattle +3 more